In another stock I own they have been applying for lots and lots of patents. Apparently the company can provide guidance to the ASX if it is price sensitive but the ASX gets the final say.
rough quote from other stock - the ASX doesnt understand the biotech space and doesnt really comprehend the significance of building strong IP protection or the value it can provide later down the track
Ann: US Patent Issued - BARD1 Patent Family Lung Cancer Diagnosis, page-5
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
47.5¢ |
Change
0.010(2.15%) |
Mkt cap ! $52.97M | |||
| Open | High | Low | Value | Volume |
| 46.5¢ | 48.5¢ | 46.5¢ | $29.32K | 61.70K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5000 | 47.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 49.0¢ | 16689 | 1 |
View Market Depth
| Last trade - 12.18pm 26/09/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |